Centiva Capital’s Replimune Group REPL Stock Holding History

Centiva Capital’s Portfolio REPL Stock Details REPL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-248,800	Closed	-$1.04M	–	1543
2025 Q3	$1.04M	Buy	248,800 +98,800	+66%	+$631K	0.01%	484
2025 Q2	$1.39M	Buy	+150,000	New	+$1.31M	0.02%	474

Other funds holding REPL

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

RCI

Ridgeback Capital Investments Miami Beach, Florida $80.9M AUM

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

SCM

Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return

BCM

Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

FIS

FCPM III Services Naarden, Netherlands $750M AUM 127.27% 1-Year Est. Return

Centiva Capital's REPL Position: Q2 2026 in Review

Centiva Capital sold out of Replimune Group (REPL) in Q2 2026, closing a stake of 18,000 shares — an estimated $138K sold.

Centiva Capital first reported a position in REPL in Q2 2024 and held it in 4 quarters. The position peaked at $690K in Q2 2025. 199 funds tracked by Wall St. Rank hold REPL as of Q2 2026.

Centiva Capital reported no remaining Replimune Group position as of Q2 2026 after selling out during the quarter.
Centiva Capital sold 18,000 Replimune Group shares in Q2 2026, an estimated $138K.
Centiva Capital first reported a position in Replimune Group in Q2 2024 and held it in 4 quarters.
Centiva Capital's Replimune Group position peaked at $690K in Q2 2025.
199 funds tracked by Wall St. Rank held Replimune Group as of Q2 2026.

Based on Centiva Capital's 13F filing for Q2 2026, filed 13 Aug 2026.